A cluster of recent studies has sharpened the scientific picture of how T cells switch on, tracking the molecular signals ...
Pertuzumab plus trastuzumab (P+T) in patients (pts) with solid tumors with ERBB2or ERBB3amplification (amp) or mutations (mut): Results from the Targeted Agent and Profiling Utilization Registry ...